Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Endocrinol Invest ; 44(11): 2445-2454, 2021 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-33738751

RESUMO

PURPOSE: To investigate predictors of testicular response and non-reproductive outcomes (height, body proportions) after gonadotropin-induced puberty in congenital hypogonadotropic hypogonadism (CHH). DESIGN: A retrospective analysis of the puberty induction in CHH male patients, undergoing an off-label administration of combined gonadotropin (FSH and hCG). METHODS: Clinical and hormonal evaluations before and during gonadotropin stimulation in 19 CHH patients genotyped by Targeted Next Generation Sequencing for CHH genes; 16 patients underwent also semen analysis after gonadotropins. RESULTS: A lesser increase in testicular volume after 24 months of induction was significantly associated with: (I) cryptorchidism; (II) a positive genetic background; (III) a complete form of CHH. We found no significant correlation with the cumulative dose of hCG administered in 24 months. We found no association with the results of semen analyses, probably due to the low numerosity. Measures of body disproportion (eunuchoid habitus and difference between adult and target height: deltaSDSth), were significantly related to the: (I) age at the beginning of puberty induction; (II) duration of growth during the induction; (III) initial bone age. The duration of growth during induction was associated with previous testosterone priming and to partial forms of CHH. CONCLUSIONS: This study shows that a strong genetic background and cryptorchidism, as indicators of a complete GnRH deficiency since intrauterine life, are negative predictors of testicular response to gonadotropin stimulation in CHH. Body disproportion is associated with a delay in treatment and duration of growth during the induction, which is apparently inversely related to previous androgenization.


Assuntos
Estatura/efeitos dos fármacos , Gonadotropina Coriônica/uso terapêutico , Criptorquidismo , Hormônio Foliculoestimulante/uso terapêutico , Predisposição Genética para Doença , Hipogonadismo , Adulto , Criptorquidismo/diagnóstico , Criptorquidismo/etiologia , Relação Dose-Resposta a Droga , Disgenesia Gonadal/tratamento farmacológico , Disgenesia Gonadal/etiologia , Gonadotropinas/uso terapêutico , Sequenciamento de Nucleotídeos em Larga Escala/métodos , Humanos , Hipogonadismo/congênito , Hipogonadismo/genética , Hipogonadismo/terapia , Masculino , Puberdade/efeitos dos fármacos , Saúde Reprodutiva/estatística & dados numéricos , Análise do Sêmen/métodos , Análise do Sêmen/estatística & dados numéricos , Testículo , Tempo para o Tratamento/normas
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...